​

Medtronic (MDT) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

MDT Stock Forecast

Medtronic (MDT) stock forecast, based on 49 Wall Street analysts, predicts a 12-month average price target of $109.67, with a high of $115.00 and a low of $103.00. This represents a 16.51% increase from the last price of $94.13.

$75 $83 $91 $99 $107 $115 High: $115 Avg: $109.67 Low: $103 Last Closed Price: $94.13

MDT Stock Rating

Medtronic stock's rating consensus is Buy, based on 49 Wall Street analysts. The breakdown includes 1 Strong Buy (2.04%), 25 Buy (51.02%), 23 Hold (46.94%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 49 23 25 1 Strong Sell Sell Hold Buy Strong Buy

MDT Price Target Upside V Benchmarks

TypeNameUpside
StockMedtronic16.51%
SectorHealthcare Stocks 15.45%
IndustryMedical Device Stocks18.84%

Price Target Trends

1M3M12M
# Anlaysts234
Avg Price Target$107.00$109.67$105.50
Last Closing Price$94.13$94.13$94.13
Upside/Downside13.67%16.51%12.08%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Oct, 25412151-32
Sep, 25412151-32
Aug, 2541313-131
Jul, 2551314-133
Jun, 25512131132
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 15, 2025Truist Financial$103.00$95.268.13%9.42%
Oct 10, 2025RBC Capital$111.00$95.7315.95%17.92%
Aug 26, 2025David ToungArgus Research$115.00$92.1824.76%22.17%
Jan 08, 2025Lee HambrightBernstein$93.00$82.6812.48%-1.20%
Oct 15, 2024David RescottRobert W. Baird$96.00$90.016.65%1.99%
Oct 10, 2024Shagun SinghRBC Capital$105.00$88.3518.85%11.55%
Oct 01, 2024Vijay KumarEvercore ISI$104.00$90.0315.52%10.49%
Oct 01, 2024Joanne WuenschCitigroup$92.00$90.032.19%-2.26%
Aug 21, 2024David RomanGoldman Sachs$82.00$86.40-5.09%-12.89%
Aug 21, 2024Steven LichtmanOppenheimer$94.00$86.468.72%-0.14%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Oct 10, 2025RBC CapitalOutperformOutperformhold
Oct 07, 2025CitigroupBuyBuyhold
Jul 15, 2025Morgan StanleyOverweightOverweighthold
Jul 11, 2025BTIGNeutralNeutralhold
Mar 04, 2025CitigroupNeutralBuyupgrade
Jan 08, 2025BernsteinOutperformOutperformhold
Nov 19, 2024NeedhamHoldHoldhold
Oct 10, 2024RBC CapitalSector PerformOutperformupgrade
Oct 08, 2024Wells FargoSector PerformSector Performhold
Oct 08, 2024RBC CapitalSector PerformSector Performhold

Financial Forecast

EPS Forecast

$2 $3 $4 $5 $6 $7 $8 Apr 21 Apr 22 Apr 23 Apr 24 Apr 25 Apr 26 Apr 27 Apr 28 Apr 29
Apr 21Apr 22Apr 23Apr 24Apr 25Apr 26Apr 27Apr 28Apr 29
Reported$2.68$3.75$2.83$2.77$3.63----
Avg Forecast$4.36$5.66$5.27$5.20$5.45$5.84$6.30$6.85$7.36
High Forecast$4.40$5.72$5.33$5.23$5.47$5.88$6.65$6.92$7.44
Low Forecast$4.31$5.60$5.22$5.19$5.44$5.76$4.95$6.78$7.29
Surprise %-38.53%-33.75%-46.30%-46.73%-33.39%----

Revenue Forecast

$25B $29B $33B $37B $41B $45B Apr 21 Apr 22 Apr 23 Apr 24 Apr 25 Apr 26 Apr 27 Apr 28 Apr 29
Apr 21Apr 22Apr 23Apr 24Apr 25Apr 26Apr 27Apr 28Apr 29
Reported$30.12B$31.69B$31.23B$32.36B$33.54B----
Avg Forecast$30.06B$32.02B$30.94B$32.22B$33.57B$35.14B$36.89B$39.10B$41.02B
High Forecast$30.30B$32.28B$31.25B$32.26B$33.65B$35.36B$36.91B$39.42B$41.35B
Low Forecast$29.82B$31.76B$30.63B$32.16B$33.47B$34.94B$36.88B$38.79B$40.70B
Surprise %0.20%-1.05%0.94%0.44%-0.11%----

Net Income Forecast

$3B $4B $6B $7B $9B $10B Apr 21 Apr 22 Apr 23 Apr 24 Apr 25 Apr 26 Apr 27 Apr 28 Apr 29
Apr 21Apr 22Apr 23Apr 24Apr 25Apr 26Apr 27Apr 28Apr 29
Reported$3.61B$5.04B$3.76B$3.68B$4.66B----
Avg Forecast$3.56B$4.39B$7.02B$4.29B$7.26B$7.74B$7.72B$9.11B$9.79B
High Forecast$4.28B$5.27B$7.09B$5.15B$7.28B$7.82B$8.85B$9.21B$9.90B
Low Forecast$2.85B$3.51B$6.94B$3.43B$7.24B$7.66B$6.58B$9.02B$9.70B
Surprise %1.18%14.78%-46.43%-14.27%-35.77%----

MDT Forecast FAQ

Is Medtronic stock a buy?

Medtronic stock has a consensus rating of Buy, based on 49 Wall Street analysts. The rating breakdown includes 1 Strong Buy, 25 Buy, 23 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Medtronic is a favorable investment for most analysts.

What is Medtronic's price target?

Medtronic's price target, set by 49 Wall Street analysts, averages $109.67 over the next 12 months. The price target range spans from $103 at the low end to $115 at the high end, suggesting a potential 16.51% change from the previous closing price of $94.13.

How does Medtronic stock forecast compare to its benchmarks?

Medtronic's stock forecast shows a 16.51% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the medical device stocks industry (18.84%).

What is the breakdown of analyst ratings for Medtronic over the past three months?

  • October 2025: 12.50% Strong Buy, 37.50% Buy, 46.88% Hold, 3.12% Sell, 0% Strong Sell.
  • September 2025: 12.50% Strong Buy, 37.50% Buy, 46.88% Hold, 3.12% Sell, 0% Strong Sell.
  • August 2025: 12.90% Strong Buy, 41.94% Buy, 41.94% Hold, 0% Sell, 3.23% Strong Sell.

What is Medtronic’s EPS forecast?

Medtronic's average annual EPS forecast for its fiscal year ending in April 2026 is $5.84, marking a 60.88% increase from the reported $3.63 in 2025. Estimates for the following years are $6.3 in 2027, $6.85 in 2028, and $7.36 in 2029.

What is Medtronic’s revenue forecast?

Medtronic's average annual revenue forecast for its fiscal year ending in April 2026 is $35.14B, reflecting a 4.79% increase from the reported $33.54B in 2025. The forecast for 2027 is $36.89B, followed by $39.1B for 2028, and $41.02B for 2029.

What is Medtronic’s net income forecast?

Medtronic's net income forecast for the fiscal year ending in April 2026 stands at $7.74B, representing an 66.11% increase from the reported $4.66B in 2025. Projections indicate $7.72B in 2027, $9.11B in 2028, and $9.79B in 2029.